Related Experiment Video
Updated: Mar 20, 2026

06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
1.1K
Baseline Antral Follicle Count Compared to Mature Oocytes Retrieved During Autologous In Vitro Fertilization Cycles
Anna E Cronin1, James Aden1, Tanya L Glenn1
1Department of Gynecologic Surgery and Obstetrics, Brooke Army Medical Center, Fort Sam Houston, TX 78234, United States.
Military Medicine
|March 18, 2026
Summary
Predicting mature oocytes from antral follicle count (AFC) in in vitro fertilization (IVF) is complex. While AFC offers some prediction, a simple model cannot accurately determine mature oocyte yield, necessitating realistic patient counseling.
Area of Science:
- Reproductive Medicine
- Infertility Research
- Assisted Reproductive Technologies
Background:
- In vitro fertilization (IVF) is a final option for infertility patients, often leading to unrealistic expectations due to social media information.
- Autologous oocyte retrieval outcomes can vary, impacting patient expectations.
Purpose of the Study:
- To assess the association between baseline antral follicle count (AFC) and mature oocytes retrieved during autologous IVF with intracytoplascialmic sperm injection (ICSI).
- To improve patient counseling by providing better predictions of mature oocyte yield.
Main Methods:
- Retrospective chart review of 362 women aged 18-41 undergoing IVF with ICSI (2015-2022).
- Collected baseline AFC and mature oocytes obtained.
- Utilized univariate and multivariate regression models to determine predictive accuracy (R-squared).
Main Results:
- Baseline AFC predicted 26.7% of mature oocytes retrieved (R-squared = 0.267).
- One mature oocyte was obtained for approximately every four baseline AFC.
- Multivariate models showed only marginal improvement in prediction (R-squared = 0.325); age was a weaker predictor (R-squared = 0.085).
Conclusions:
- A simple, highly accurate model to predict mature oocytes from baseline AFC was not achieved.
- Significant variability exists in oocyte yield prediction, emphasizing the complexity of infertility.
- Findings underscore the need for comprehensive patient counseling regarding expected outcomes and response variations in IVF.
Related Concept Videos
In Vitro Fertilization
1.3K
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.3K
Oogenesis
71.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.1K
Ovarian Cycle
5.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.0K

